1198 results

Effects of anemia and blood transfusion on clot formation and platelet function in patients with septic shock: a substudy of the randomized TRISS trial

A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled

The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted nearinfrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.

Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments.

The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings.

The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.

PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment

A randomized phase II feasibility trial of a multimodalintervention for the management of cachexia in lungand pancreatic cancer.